Literature DB >> 34585698

Safflower yellow reduces DEN-induced hepatocellular carcinoma by enhancing liver immune infiltration through promotion of collagen degradation and modulation of gut microbiota.

Huiying Fu1,2, Xia Liu1,2, Lu Jin1,2, Jiali Lang1, Zhiming Hu3, Wen Mao1, Changpei Cheng4, Qiyang Shou1,2.   

Abstract

Safflower yellow (SY) is the main active ingredient isolated from the traditional Chinese medicine Carthamus tinctorius, which is a valuable natural edible pigment that is widely used to treat cerebrovascular and cardiovascular diseases. However, the effect of SY on hepatocellular carcinoma (HCC) remains unclear. In this study, we showed that SY decreased the degree of injury and inhibited the release of inflammatory factors in the liver of a diethylnitrosamine (DEN)-induced HCC mouse model. Flow cytometry and immunoblotting showed that SY increased the infiltration of CD8+ T cells and Gr-1+ macrophages to improve the immune microenvironment by affecting the expression of collagen fibers. Further cellular experiments showed that SY degraded the collagens in the liver cells through the TGF-β/Smad signalling pathway. SY also regulated the gut microbiota which may contribute to the immune microenvironment. In conclusion, SY exhibited a potent effect on the development of HCC by enhancing liver immune infiltration by promoting collagen degradation and modulating the gut microbiota. This study provides novel insights into the mechanism of SY as a candidate for the treatment of HCC in the future.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34585698     DOI: 10.1039/d1fo01321a

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  1 in total

1.  Inhibitory Effects of Mongolian Medicine Yihe-Tang on Continuous Darkness Induced Liver Steatosis in Zebrafish.

Authors:  Rigaiqiqige Sa; Chi Feng; Hongxia Bai; Xiaoyu Yin; Lei Song; Xiaodong Hu; Rui Xu; Xinshan Li; Wu Dong; Jingfeng Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-20       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.